Synagis

In the US, SYNAGIS (palivizumab systemic) is a member of the drug class immune globulins and is used to treat Respiratory Syncytial Virus.

US matches:

• Synagis

UK matches:

• Synagis 100mg
• Synagis 50mg
• Synagis (SPC)

Ingredient matches for SYNAGIS

Palivizumab

Palivizumab is reported as an ingredient of SYNAGIS in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Canada


• Chile


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• Egypt


• El Salvador


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Iran


• Iraq


• Ireland


• Italy


• Japan


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Poland


• Qatar


• Slovakia


• Slovenia


• South Africa


• Sudan


• Sweden


• Switzerland


• Syria


• Taiwan


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.